Transvaginal Botulinum Toxin A Chemodenervation for Overactive Bladder

NCT05463822 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder
Bladder, Overactive
Urge Incontinence
Urgency Urinary
Urinary Frequency/Urgency

Interventions

DRUG: Transvaginal botulinum toxin A (BTA) injection

Sponsor

Stanford University

Collaborators

[object Object]